Skip to content

To characterize the care pathway flow of postâ??acute myocardial infarction (MI) patients as a result of standard assessments of left ventricular ejection fraction

Improve SCA Bridge

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/017004
Enrollment
2400
Registered
2019-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

None listed

Sponsors

India Medtronic Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 and above ( or meet age requirements per local law) Patients who have acute Myocardial Infarction ( MI) ( STEMI of Non-STEMI) less than equal to 30 days of study enrollment and have a LVEF less than 50% measurement less than equal to 14 days post-acute MI Willing and able to give valid Informed Consent

Exclusion criteria

Exclusion criteria: Patient has previously recieved or currently implanted with an ICD or CRT-D Patient has any contraindication for ICD/CRT-D Patient has a life expectancy of less than 12 months Patient who has had and EP referral within the last 12 months Any exclusion criteria required by local law (e.g. pregnancy, breast feeding etc.) Patient is unable ( e.g. mental disorder) or unwilling to be compliant with the responsibilities as specified in the informed consent form. Patient is enrolled in a concurrent study that has not been approved for concurrent enrollment by the Medtronic Clinical Trial Leader

Design outcomes

Primary

MeasureTime frame
To characterize the proportion of post-acute MI patients who are referred for suddden cardiac death (SCD) risk startification and management.Timepoint: 12 months

Secondary

MeasureTime frame
Characterize the proportion of postâ??acute MI patients who are known to be indicated for an ICD/CRTâ??D within 12 months postâ??acute MI. Characterize the proportion of postâ??acute MI patients who receive an ICD/CRTâ??D within 12 months postâ??acute MI. Summarize the referral and implant refusal rationale. Characterize the proportion of postâ??acute MI patients who experience cardiovascular mortality Determine how the ejection fraction evolves over 3 months following an acute MI.Timepoint: 3 months and 1 year

Countries

Bangladesh, Brunei Darussalam, China, Egypt, India, Indonesia, Malaysia, Other, Pakistan, Philippines, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand, Tunisia

Contacts

Public ContactVinay Rajan PhD

India Medtronic Pvt Ltd

vinay.rajan@medtronic.com02233074700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026